At TruTag Technologies, we have devoted our energy and competency to developing a one-of-a-kind security and technology solution to businesses and governments around the world. TruTag is dedicated to the development of precision-fabricated nano-porous silica for a variety of applications and security solutions, including product identity for pharmaceutical and nutraceutical companies; secure labels and documents; and precision drug delivery systems for biotech companies. TruTag’s technology platform expertise also includes advanced hyperspectral imaging solutions, which can be applied to a broad array of market applications from medical diagnostics to machine vision.
Our award-winning authentication technology platform uses microscopic particles that serve as covert “edible bar codes.” These microtags contain a spectral code chosen from a vast library that are associated with a secure database containing extensive product information. For example, when integrated into pharmaceutical products, these microtags can be used to track drug product to help accurately determine the identification and supply chain history of an individual dose, as well as confirm the authenticity of manufacture and country of authorized sale, helping to fight against diversion and falsification. TruTag microtags are made of high purity silica, which is a material commonly used in food and medicine and “generally recognized as safe,” or GRAS, by the U.S. Food and Drug Administration.
We have partnered with biotech firms who utilize our precision silica material platform for targeted, in vivo drug delivery to provide more effective treatment using long-term extended release to localized sites. Due to the heat resistance of our silica and other properties making it highly durable, the microparticles can also be used with industrial parts, electronic components, and many consumer products. Additionally, our advanced detection systems are used to identify and decode these coded microtagsafter embedded on or in high-value products and components. The state-of-the-art hyperspectral imaging engine used in our microtag readers is also commercially available to other industries, and TruTag is the first to bring these technologies from the research lab to mass production capability.
We have manufacturing facilities in Hawaii, engineering offices in California, and business development offices in Pennsylvania, Texas, China and Singapore. TruTag’s early technology research was funded in part by the U.S. Army Medical Research division. The company is supported by venture capital firms and strategic corporate investors.